Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.190
-0.020 (-1.65%)
At close: Apr 28, 2026, 4:00 PM EDT
1.190
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $37.10 million as of April 28, 2026. Its market cap has increased by 3.34% in one year.
Market Cap
37.10M
Enterprise Value
-8.27M
1-Year Change
3.34%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $37.10M, an increase of 122.15%. That is a compound annual growth rate of 6.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 38.00M | -10.38% |
| Dec 31, 2025 | 42.40M | 7.89% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 43.10M |
| Lite Strategy | 42.91M |
| Sensei Biotherapeutics | 42.61M |
| Atara Biotherapeutics | 40.97M |
| Aligos Therapeutics | 39.60M |
| Werewolf Therapeutics | 39.51M |
| RenovoRx | 38.59M |
| NextCure | 37.46M |